Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvs save search
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
Published: 2024-02-27 (Crawled : 15:30) - biospace.com/
TSVT | $4.985 -1.09% -1.1% 480
|
|
| O: 0.0%
H: 8.64%
C: 8.36%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.15%
H: 0.31%
C: 0.06%
BLBD | $35.235 -0.83% 12K
|
Producer Manufacturing
|
| O: 1.02%
H: 1.29%
C: 1.17%
ALVR | $0.7461 650K
|
Health Technology
|
| O: -1.42%
H: 7.9%
C: 3.52%
ADAP | $1.055 0.48% 49K
|
Health Technology
|
| O: 3.05%
H: 5.92%
C: 1.18%
pdufa commercial
New England Journal of Medicine publishes Phase III data showing Xolair® (omalizumab) significantly reduced allergic reactions across multiple foods in people with food allergies
Published: 2024-02-25 (Crawled : 20:20) - prnewswire.com
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.65%
H: 0.07%
C: -1.27%
xolair food foods
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 0.37%
H: 0.58%
C: 0.58%
VTRS | $11.32 -0.09% -0.09% 0
|
Health Technology
|
| O: 0.0%
H: 1.93%
C: 1.27%
NVO | $123.9 -0.49% -0.69% 20K
|
Health Technology
|
| O: -0.68%
H: 0.4%
C: -0.18%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.89%
H: 0.4%
C: 0.17%
JNJ | $144.67 -1.98% 1.5M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
report revenue global insulin growth market
United States Pharmaceuticals Market Size to Surpass US$ 1,068.02 Billion by 2030 | Exhibiting a CAGR of 8.6% Says CoherentMI
Published: 2024-02-22 (Crawled : 18:00) - prnewswire.com
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 0.37%
H: 0.58%
C: 0.58%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.89%
H: 0.4%
C: 0.17%
LLY | $747.51 -0.43% 150K
|
Health Technology
|
| O: 0.57%
H: 0.47%
C: -0.58%
BMY | $48.51 0.48% 0.47% 8.6K
|
Health Technology
|
| O: 0.14%
H: 1.01%
C: 0.51%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 0.29%
H: 0.93%
C: 0.47%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
GILD | $67.39 -0.53% 240K
|
Health Technology
|
| O: 0.65%
H: 1.35%
C: 0.41%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: 0.47%
H: 2.0%
C: 0.93%
pharmaceuticals market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: -0.0%
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 0.26%
H: 1.36%
C: 1.36%
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: -0.85%
H: 1.12%
C: 0.43%
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: 0.0%
UCBJY | $63.0 -1.37% -4.38% 0
|
Manufacturing
|
| O: 1.46%
H: 0.44%
C: 0.44%
ALPMY | $9.2715 -2.92% 0
|
Manufacturing
|
| O: -0.27%
H: 0.0%
C: -1.17%
TAK | $13.18 -1.42% 0.38% 7.3K
|
Health Technology
|
| O: -0.2%
H: 0.14%
C: -0.48%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.06%
H: 0.46%
C: 0.29%
GSK | $39.765 -1.82% 260K
|
Health Technology
|
| O: -0.69%
H: 1.42%
C: 1.22%
LLY | $747.51 -0.43% 150K
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
BMY | $48.51 0.48% 0.47% 8.6K
|
Health Technology
|
| O: -0.65%
H: 1.63%
C: 1.48%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: -0.88%
H: 1.46%
C: 1.13%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: 0.0%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -2.81%
H: 2.08%
C: 1.38%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: -0.35%
H: 1.15%
C: 0.96%
lung reach cancer cell diagnostics therapy market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published: 2024-02-21 (Crawled : 02:00) - prnewswire.com
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: -0.88%
H: 1.75%
C: -0.29%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.65%
H: 0.62%
C: 0.5%
LLY | $747.51 -0.43% 150K
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -1.01%
H: 1.1%
C: 1.1%
report reach research global diabetes market
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published: 2024-02-20 (Crawled : 03:00) - prnewswire.com
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 2.81%
H: 0.0%
C: -0.95%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 2.91%
H: 0.35%
C: -0.38%
BIIB | $195.56 -0.63% 13K
|
Health Technology
|
| O: -0.69%
H: 1.24%
C: 0.76%
disease biosimilar report global market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $195.56 -0.63% 13K
|
Health Technology
| Email alert
Add to watchlist
VTRS | $11.32 -0.09% -0.09% 0
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.35 -0.55% 330K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.765 -1.82% 260K
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
| Email alert
Add to watchlist
JAZZ | $110.65 -0.23% 20K
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $265.56 0.02% 85K
|
Health Technology
| Email alert
Add to watchlist
cancer cell global growth market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published: 2024-02-16 (Crawled : 23:00) - prnewswire.com
BHC | $8.52 -1.28% 48K
|
Health Technology
| Email alert
Add to watchlist
ALC | $81.09 -0.23% -1.05% 19K
|
Health Technology
| Email alert
Add to watchlist
STAA | $46.22 -7.17% -7.72% 75
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
| Email alert
Add to watchlist
JNJ | $144.67 -1.98% 1.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
| Email alert
Add to watchlist
report global diabetes market
Global Advanced Drug Delivery Systems Market Report 2024: Review of Patents and Patent Applications Filed on Drug Delivery Release Mechanisms and Novel Applications
Published: 2024-02-15 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.504 -4.67% -17.59% 0
|
Health Technology
|
| O: 0.79%
H: 0.0%
C: -3.21%
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.59%
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 1.66%
H: 0.0%
C: -1.04%
TRUMY | $16.53 -1.37% 0.79% 0
|
Manufacturing
|
| O: 0.27%
H: 0.0%
C: -2.6%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.37%
H: 0.57%
C: 0.19%
JNJ | $144.67 -1.98% 1.5M
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
drug patent report review global advanced market
Global Biosimilar Monoclonal Antibodies Market Report 2024: Future Market Growth Powered by Biologics and Personalized Therapy Advances
Published: 2024-02-14 (Crawled : 20:00) - prnewswire.com
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.26%
H: 0.87%
C: 0.32%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 0.48%
H: 1.56%
C: 1.48%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: -0.75%
H: 0.86%
C: 0.41%
biosimilar report global therapy growth market
Genmab Publishes 2023 Annual Report
Published: 2024-02-14 (Crawled : 16:00) - globenewswire.com
GNMSF | $282.004 -3.13% 0
|
Health Technology
|
| O: 2.65%
H: 4.56%
C: 1.23%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: 0.01%
JNJ | $144.67 -1.98% 1.5M
|
Health Technology
|
| O: -0.91%
H: 0.0%
C: 0.0%
GMAB | $29.0 -1.73% 19K
|
Health Technology
|
| O: 1.32%
H: 5.34%
C: 3.02%
report
Erasca Announces Two Clinical Trial Collaboration and Supply Agreements for Trametinib to Evaluate Naporafenib Combination in SEACRAFT-1 and SEACRAFT-2 Trials
Published: 2024-02-14 (Crawled : 13:00) - globenewswire.com
ERAS | $1.97 -1.5% 19K
|
|
| O: 2.99%
H: 2.03%
C: 0.58%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: 0.01%
trials collaboration trial
Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published: 2024-02-13 (Crawled : 00:00) - prnewswire.com
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.02%
H: 0.24%
C: 0.01%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
disease reach market
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | $9.2715 -2.92% 0
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | $13.18 -1.42% 0.38% 7.3K
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | $144.67 -1.98% 1.5M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | $39.765 -1.82% 260K
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | $747.51 -0.43% 150K
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.51 0.48% 0.47% 8.6K
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | $14.2 -0.77% -0.88% 0
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | $397.36 0.2% 0.23% 650
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.42 4.5K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $53.55 0.22% 32K
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $195.56 -0.63% 13K
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $366.575 -2.57% 32K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Positron Emission Tomography Market to Record US $ 725.97 million Growth between 2023 to 2028 | Market Share, Trends, Drivers, and Opportunity Assessment | Technavio
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
CAJPY | $28.92 -0.17% 1
|
n/a
|
| O: 1.12%
H: 0.0%
C: -1.22%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
PHG | $20.41 1.75% 0.93% 5.5K
|
Health Technology
|
| O: -2.76%
H: 0.45%
C: -0.2%
million growth market
Global Epidural Abscess Treatment Market Report 2024 - Treatment Advances and Digital Health Technologies Shaping the Future of Epidural Abscess Care
Published: 2024-02-12 (Crawled : 15:30) - prnewswire.com
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: -0.57%
H: 0.04%
C: -1.74%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -1.46%
H: 1.04%
C: 0.97%
LLY | $747.51 -0.43% 150K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.48%
BMY | $48.51 0.48% 0.47% 8.6K
|
Health Technology
|
| O: 0.02%
H: 0.46%
C: -0.14%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: -0.83%
H: 0.7%
C: -0.27%
ABT | $108.89 2.4K
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -1.77%
H: 0.46%
C: 0.41%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: -0.4%
H: 1.6%
C: 1.54%
report health treatment care global market
Orphan Drugs Market Projection: BCC Research Anticipates a Staggering $415.2 Billion Valuation by 2028, Reflecting Soaring Global Demand
Published: 2024-02-09 (Crawled : 10:00) - prnewswire.com
ALPMF | $9.48 -8.41% 1.8K
|
Health Technology
|
| O: -0.91%
H: 3.88%
C: 3.88%
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: -2.6%
H: 2.26%
C: 1.44%
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: -2.46%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -2.92% 0
|
Manufacturing
|
| O: 4.66%
H: 0.0%
C: -3.92%
PFE A | $25.91 0.19% 0.08% 140K
|
Health Technology
|
| O: -0.04%
H: 0.11%
C: 0.0%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -0.37%
H: 0.21%
C: 0.05%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -1.28%
H: 1.05%
C: -0.72%
research global market
Generic Drugs Market to grow by USD 176.25 billion from 2022 to 2027, North America is estimated to contribute 37% to the growth - Technavio
Published: 2024-02-08 (Crawled : 05:00) - prnewswire.com
ENDPQ 6 d | $0.0018 500.0% 0
|
n/a
|
| O: -14.29%
H: 16.67%
C: 0.0%
GLAXF | $20.2 0.65% -14.18% 0
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
SNYNF | $92.966 0.07% -2.18% 0
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
VTRS | $11.32 -0.09% -0.09% 0
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: -1.2%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: -1.57%
H: 0.26%
C: -0.47%
GSK | $39.765 -1.82% 260K
|
Health Technology
|
| O: -0.48%
H: 0.16%
C: 0.0%
BAX | $39.72 -0.8% 70K
|
Health Technology
|
| O: -0.96%
H: 5.91%
C: 3.74%
ABT | $108.89 2.4K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: 0.38%
H: 0.34%
C: -0.72%
america growth market
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $135.94 -2.12% -4.19% 0
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 -0.49% 6.88% 400
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
NVS | $94.41 0.95% -1.63% 8.1K
|
Health Technology
|
| O: 0.09%
H: 0.39%
C: -0.36%
GSK | $39.765 -1.82% 260K
|
Health Technology
|
| O: 0.43%
H: 0.67%
C: 0.21%
BAX | $39.72 -0.8% 70K
|
Health Technology
|
| O: 0.21%
H: 0.24%
C: -1.04%
ABBV | $161.67 -0.38% 0.43% 5.3K
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | $46.24 0.68% 0.63% 0
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BMRN S | $90.26 -1.37% 29K
|
Health Technology
|
| O: -0.38%
H: 1.79%
C: 0.22%
AZN | $68.35 -0.55% 330K
|
Health Technology
|
| O: -0.4%
H: 0.19%
C: -0.33%
AMGN | $265.56 0.02% 85K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
america therapeutics growth market
Gainers vs Losers
| 36% | 64% |
Top 10 Gainers
JAGX | $0.1668 40.4% 110M
|
Health Technology
MCBC | $13.84 39.38% 450K
|
Finance
ITCI | $80.21 23.86% 2M
|
Health Technology
IINN | $2.17 12.44% 57K
|
Manufacturing
BRTX | $1.475 11.74% 6.5M
|
Professional, Scientific, and T...
CBAT | $1.01 9.78% 160K
|
Producer Manufacturing
FANH | $4.06 9.73% 8K
|
Finance
BCAN | $0.8378 8.81% 1.1M
|
Construction
GFAI | $2.91 8.18% 38K
|
HUMA | $3.07 6.97% 360K
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.